These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33336604)

  • 1. Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery.
    Luo N; Li J; Chen Y; Xu Y; Wei Y; Lu J; Dong R
    Drug Deliv; 2021 Dec; 28(1):10-18. PubMed ID: 33336604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted activation of
    Luo N; Zhong W; Li J; Zhai Z; Lu J; Dong R
    Nanomedicine (Lond); 2022 Aug; 17(20):1411-1427. PubMed ID: 36326013
    [No Abstract]   [Full Text] [Related]  

  • 3. CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges.
    Luo N; Zhong W; Li J; Lu J; Dong R
    Mol Biol Rep; 2022 Dec; 49(12):11403-11408. PubMed ID: 35960410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Comparison between VP64-dCas9-VP64 and dCas9-VP192 CRISPR Activators in Human Embryonic Kidney Cells.
    Javaid N; Pham TLH; Choi S
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of dCas9-VP64 variants and multiplexed guide RNAs mediating CRISPR activation.
    Omachi K; Miner JH
    PLoS One; 2022; 17(6):e0270008. PubMed ID: 35763517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Transcriptional Activation in Plants Using Multiplexed CRISPR-Act2.0 and mTALE-Act Systems.
    Lowder LG; Zhou J; Zhang Y; Malzahn A; Zhong Z; Hsieh TF; Voytas DF; Zhang Y; Qi Y
    Mol Plant; 2018 Feb; 11(2):245-256. PubMed ID: 29197638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Act2.0: An Improved Multiplexed System for Plant Transcriptional Activation.
    Malzahn A; Zhang Y; Qi Y
    Methods Mol Biol; 2019; 1917():83-93. PubMed ID: 30610630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene activation by a CRISPR-assisted
    Xu X; Gao J; Dai W; Wang D; Wu J; Wang J
    Elife; 2019 Apr; 8():. PubMed ID: 30973327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Easy and Efficient Strategy for the Enhancement of Epothilone Production Mediated by TALE-TF and CRISPR/dcas9 Systems in
    Ye W; Liu T; Zhu M; Zhang W; Huang Z; Li S; Li H; Kong Y; Chen Y
    Front Bioeng Biotechnol; 2019; 7():334. PubMed ID: 32039165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
    Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer.
    Liu C; Wang N; Luo R; Li L; Yang W; Wang X; Shen M; Wu Q; Gong C
    Theranostics; 2021; 11(20):9833-9846. PubMed ID: 34815789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic activation of cardiosphere-derived cells enhances myocardial repair.
    Sano T; Ito T; Ishigami S; Bandaru S; Sano S
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1479-1490.e5. PubMed ID: 32682583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells.
    Wan L; Xia T; Du Y; Liu J; Xie Y; Zhang Y; Guan F; Wu J; Wang X; Shi C
    FASEB J; 2019 Jul; 33(7):8530-8542. PubMed ID: 30970216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9.
    Li Z; Zhou X; Wei M; Gao X; Zhao L; Shi R; Sun W; Duan Y; Yang G; Yuan L
    Nano Lett; 2019 Jan; 19(1):19-28. PubMed ID: 30517011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenome editing based on CRISPR/dCas9
    Huang H; Zhang W; Zhang J; Zhao A; Jiang H
    Exp Cell Res; 2023 Apr; 425(2):113551. PubMed ID: 36914062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmable activation of Bombyx gene expression using CRISPR/dCas9 fusion systems.
    Wang XG; Ma SY; Chang JS; Shi R; Wang RL; Zhao P; Xia QY
    Insect Sci; 2019 Dec; 26(6):983-990. PubMed ID: 30088341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced intrinsic CYP3A4 activity in human hepatic C3A cells with optically controlled CRISPR/dCas9 activator complex.
    Han S; Wei S; Wang X; Han X; Zhang M; Su M; Li Y; Guo J; Zeng W; Liu J; Gao Y; Shen L
    Integr Biol (Camb); 2018 Dec; 10(12):780-790. PubMed ID: 30520487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects.
    Rahman MM; Tollefsbol TO
    Methods; 2021 Mar; 187():77-91. PubMed ID: 32315755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-assisted transcription activation by phase-separation proteins.
    Liu J; Chen Y; Nong B; Luo X; Cui K; Li Z; Zhang P; Tan W; Yang Y; Ma W; Liang P; Songyang Z
    Protein Cell; 2023 Dec; 14(12):874-887. PubMed ID: 36905356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis.
    Seo W; Eun HS; Kim SY; Yi HS; Lee YS; Park SH; Jang MJ; Jo E; Kim SC; Han YM; Park KG; Jeong WI
    Hepatology; 2016 Aug; 64(2):616-31. PubMed ID: 27178735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.